Should a biopsy precede liver resection or transplantation for presumed hepatocellular carcinoma when the alfa fetoprotein is normal? [5]

Transplantation

Volumn 77, Issue 4, 2004, Pages 637-638

  Shawcross, Debbie L ^a   Naoumov, Nickolai ^a   Pachiadakis, Ioannis ^a   Mamais, Constantinos ^a   Williams, Roger ^a   Jalan, Rajiv ^a,b   Gillams, Alice ^a   Lees, William ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FATTY LIVER; FEMALE; HUMAN; LETTER; LIVER BIOPSY; LIVER CARCINOMA; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

AGED; ALPHA-FETOPROTEINS; BIOPSY; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 1442286822     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000109783.98513.E3     Document Type: Letter

References (3)

1. Oka H, Tamori A, Kuroki T, et al. Prospective study of alfa fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994; 19: 61.
2. Bruix J, Sherman M, Llovet J, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference. J Hepatol 2001; 35: 421.
3. Durand F, Regimbeau JM, Belghiti J, et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001; 35: 254.